| HOME >> BIOLOGY >> TECHNOLOGY |
Seeks Injunction in the United States and Canada and Monetary Damages
SAN DIEGO, Jan. 16 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it filed two patent infringement lawsuits against CryoCath Technologies Inc., one in the United States District Court for the District of Delaware and one in Canada.
The lawsuits allege that CryoCath's products infringe several patents related to CryoCor's Cardiac Cryoablation System. CryoCor is an exclusive licensee of the patents, and is seeking monetary damages and injunctions in the United States and Canada to prohibit further infringement.
Ed Brennan, Ph.D., President and Chief Executive Officer of CryoCor, said, "We believe that our exclusive license to these patents gives us broad coverage over key technologies that are critical in the field of cryoablation for cardiovascular applications. We have filed this lawsuit against CryoCath to enforce our intellectual property rights related to this critical segment of healthcare."
CryoCor has previously announced that it is pursuing patent interference proceedings initiated in 2004 with the United States Patent and Trademark Office. CryoCor's believes that it, through the licensor, was the first to invent certain pre-cooling technologies and is seeking that an interference be declared between CryoCath patents and CryoCor intellectual property to determine right of invention and ownership. CryoCor reported that it expects a patent interference proceeding to be declared by the U.S.P.T.O. in the first half of 2008.
About CryoCor
CryoCor is a medical technology company that has developed and
manufactures a disposable catheter system based on its proprietary
cryoablation technology for the minimally invasive treatment of cardiac
arrhythmias. The Company's product, the CryoCor Cardiac Cryoablation
System, or the Cryoablation System, is des
'/>"/>
| SOURCE CryoCor, Inc. Copyright©2008 PR Newswire. All rights reserved |